Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine.

Area of Science:

• Critical Care Medicine
• Cardiovascular Physiology
• Renal Physiology

Background:

• Septic shock with acute respiratory failure presents complex hemodynamic challenges.
• Optimizing systemic vascular resistance (SVR) and cardiac index (CI) is crucial for patient outcomes.
• Oliguria is a common complication requiring effective therapeutic interventions.

Purpose of the Study:

• To evaluate the efficacy of norepinephrine (NE) alone or with dobutamine in managing septic shock.
• To achieve target hemodynamic parameters: CI ≥ 4.5 L/min/m², SVR ≥ 700-800 dyn·s·cm⁻⁵, and oxygen delivery (Do2) ≥ 550 mL/min/m².
• To assess the impact of NE on urine flow and overall septic shock resolution.

Main Methods:

• Twenty-three patients with septic shock and acute respiratory failure were studied after initial fluid resuscitation.
• Patients were categorized into hyperdynamic (CI > 4.5 L/min/m²) or normodynamic/hypodynamic (CI < 3.5 L/min/m²) groups.
• NE was administered as a single agent or in combination with dobutamine based on hemodynamic status and response.

Main Results:

• NE infusion successfully increased SVR to > 700 dyn·s·cm⁻⁵ and CI to ≥ 4.5 L/min/m² in all patients.
• Oxygen delivery (Do2) was maintained above 550 mL/min/m² during NE therapy.
• Urine flow significantly increased, with only four patients remaining oliguric; 70% of patients achieved complete septic shock resolution.

Conclusions:

• Norepinephrine is an effective agent for managing septic shock, achieving target hemodynamic goals.
• NE therapy improves systemic vascular resistance, cardiac index, and urine output in critically ill patients.
• While effective, hospital mortality remains high at 56%, indicating the severity of septic shock.